Cargando…
Recent Advances and Impact of Chemotherapeutic and Antiangiogenic Nanoformulations for Combination Cancer Therapy
Traditional chemotherapy, along with antiangiogenesis drugs (combination cancer therapy), has shown reduced tumor recurrence and improved antitumor effects, as tumor growth and metastasis are often dependent on tumor vascularization. However, the effect of combination chemotherapy, including synergi...
Autores principales: | Rajora, Amit Kumar, Ravishankar, Divyashree, Zhang, Hongbo, Rosenholm, Jessica M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356724/ https://www.ncbi.nlm.nih.gov/pubmed/32630584 http://dx.doi.org/10.3390/pharmaceutics12060592 |
Ejemplares similares
-
Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy
por: Chen, Fangmin, et al.
Publicado: (2021) -
Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer
por: Mukherjee, Anubhab, et al.
Publicado: (2020) -
Antiangiogenic Targets for Glioblastoma Therapy from a Pre-Clinical Approach, Using Nanoformulations
por: Nery de Albuquerque Rego, Gabriel, et al.
Publicado: (2020) -
Recent Advances in Nanoformulations for Quercetin Delivery
por: Tomou, Ekaterina-Michaela, et al.
Publicado: (2023) -
Nano Differential Scanning Fluorimetry as a Rapid Stability Assessment Tool in the Nanoformulation of Proteins
por: Lisina, Sofia, et al.
Publicado: (2023)